comparemela.com

Latest Breaking News On - Amphastar pharmaceuticals - Page 9 : comparemela.com

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, and will hold a conference call to discuss its financial results at.

Exchange commissionCompany informationAmphastar pharmaceuticals incMost of the companyAmphastar pharmaceuticalsAnnual report

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Most of the companyCompany informationAmphastar pharmaceuticals incExchange commissionAmphastar pharmaceuticalsAnnual report

Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies

At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc AMPH highlighted why they remain excited about Baqsimi, the inhaled glucagon product for…

Amphastar pharmaceuticalsAmphastar pharmaceuticals incNeedham healthcare conferenceReaking news

Pharvaris Appoints David Nassif, J D , as Chief Financial Officer

Pharvaris Appoints David Nassif, J D , as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesBerndt modigDavid nassifMaggie bellerMorgan connUniversity of virginiaEuropean unionAmphastar pharmaceuticalsUniversity of virginia school lawExchange commissionCypros pharmaceuticalsQuestcor pharmaceuticalsAppoints david nassifChief financialChief financial officerChief executive officer

Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies - Eli Lilly and Co (NYSE:LLY), Amphastar Pharma (NASDAQ:AMPH)

Amphastar Pharmaceuticals discusses the future of Baqsimi at the Needham Healthcare Conference, highlighting its potential amid a growing market for glucagon products. With promising sales projections and strategic initiatives, Amphastar aims to capitalize on emerging opportunities in the endocrinology sector for continued growth.

Amphastar pharmaceuticals incAmphastar pharmaceuticalsNeedham healthcare conferenceEli lilly and

vimarsana © 2020. All Rights Reserved.